billed via G0108/G0109 Smoking cessation: Critical smoking dramatically accelerates all DM macrovascular and microvascular complications Pharmacologic Targets (ADA 2026) A1C target: 20): Finerenone (non-steroidal MRA), SGLT-2 inhibitors per ADA 2026 updated CKD recommendations Monitoring Technologies Continuous glucose monitoring (CGM): ADA 2026 Recommendation 13.5 recommended for all Type 1 DM
Vitamin C and its antioxidant activity has been said to reduce inflammation and also lower the risk of some cancers - this is being continuously examined by governing health bodies across the world
Contraindications AOD-9604 peptide therapy may not be suitable for individuals who: Are pregnant or breastfeeding Are under the age of 18 Have active or recent malignancy A consultation is required to determine suitability prior to starting therapy
We serve patients from Fort Lauderdale, FL, North Lauderdale FL, Pompano Beach FL, Plantation FL, Royal Palm Beach FL, Wellington FL, Westlake FL, Golden Lakes FL, and surrounding areas